Yueyin Venture Capital

Yueyin Venture Capital is an investment institution specializing in the healthcare sector. It aims to enhance patient care by focusing on medical services across three key dimensions: disease types, emerging technologies, and the industrial chain related to medical services. The firm invests in various fields, including medical devices, biomedicine, in vitro diagnostics, and smart medical solutions. Established by professionals from both the medical and investment sectors, Yueyin Venture Capital is committed to fostering the growth and innovation of the domestic medical and health industry in China.

You Linlin

Executive Director

14 past transactions

Hygea Medical

Series D in 2023
Hygea Medical Technology Co. Ltd. is a Beijing-based company that specializes in the design and manufacture of medical equipment aimed at anti-tumor treatments. The company focuses on oncology, developing solutions for cancer therapies that target diseases affecting the lung, liver, breast, and kidney. Hygea Medical is committed to advancing its micro-invasive and Cryo-HIT technology, which is utilized in cryosurgery and cryopreservation. By prioritizing research and development, Hygea Medical aims to enhance the efficiency of treatment for tumor-related diseases.

Tsingke Biotech

Series A in 2022
Tsingke Biotechnology focuses on the research and development of synthetic genomics and biosynthetic products. The company operates in three primary areas: providing synthetic genomics products and services, offering life science research equipment and raw materials, and delivering biomanufacturing contract research and development services. Through these endeavors, Tsingke aims to contribute to advancements in biotechnology and support various applications in life sciences.

Kossel Medical

Venture Round in 2022
Kossel Medical specializes in the research and development of vascular interventional medical devices. The company manufactures a range of products, including coronary stent systems, PTA balloon catheters, and electrophysiology devices. By focusing on these areas, Kossel Medical aims to enhance clinical treatment options for patients, providing innovative solutions in the field of interventional cardiology and vascular care.

GX Pharma

Venture Round in 2020
GX Pharma is a contract research organization (CRO) that specializes in the research and development of new drugs and clinical research. The company provides comprehensive clinical research services and registration solutions for novel drugs, biological products, and medical devices. By streamlining the product listing cycle, GX Pharma helps its clients expedite the market introduction of their products. Since 2018, GX Pharma has been recognized as one of the top outsourcing companies in China's pharmaceutical industry, reflecting its commitment to excellence and innovation in the field.

TCR Cure

Series B in 2019
Chongqing TCRCure Biotechnology Co., Ltd. is a Beijing-based company that specializes in the research, development, and industrialization of tumor immune cell therapies. The firm offers a range of products and services, including universal T cell receptor chimeric T cell therapy, individualized TCR tumor immune cell customization therapy, and CAR-T therapy. Additionally, TCRCure is involved in clinical immune monitoring and immunological efficacy assessment, as well as providing virus and carrier production for external technical services. The company emphasizes a streamlined approach to biotechnology development, focusing on high throughput antigen-specific TCR cloning, industry-scale virus production, T cell genetic engineering, and immune cell manufacturing.

Hanyu Medical

Series B in 2018
Hanyu Medical is a pioneering company in the development, production, and sale of transcatheter mitral valve repair devices, focusing on innovative solutions for heart valve diseases. Its primary product, Valve Clamp, is an interventional device designed for minimally invasive treatment of mitral valve regurgitation. This device facilitates the closure of heart valves during operations, allowing surgeons to perform heart surgeries with reduced invasiveness. Hanyu Medical's commitment to advancing medical technology positions it as a significant player in the cardiovascular device market.

Yidianling

Series A in 2018
Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.

Yidianling

Series A in 2018
Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.

Rivamed

Series A in 2018
Rivamed specializes in logistics management systems and medical material management solutions utilizing Hospital Internet of Things (HIoT) technology to enhance the integration of medical resources. The company’s offerings focus on improving the efficiency of medical staff while reducing operational errors. Rivamed provides a range of products, including intelligent storage solutions, medical devices, printers, and drug management cabinets, all designed to support closed-loop management of medical intelligent IoT through independent innovation. Their advanced management concepts aim to streamline processes in the medical field, ensuring better resource utilization and overall operational effectiveness.

Campo Imaging

Series A in 2017
Campo Imaging is a Chinese company established in 2010 that specializes in medical imaging technology and services. The company develops and manufactures medical imaging equipment while also operating diagnostic centers that provide a range of imaging services. These services include CT scans, magnetic resonance imaging, digital radiography, ultrasound, dynamic electrocardiograms, tele-consultation, and consultations for complex cases. Campo Imaging aims to enhance the medical imaging experience, enabling patients to access vital health services in a convenient and efficient manner.

GenomePrecision

Series A in 2017
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.

Mingyizhudao

Series B in 2016
mingyizhudao is the leading Internet + surgery platform and the only medical case sharing economic case research base in China. Its gold medal product “Medical Doctor” was launched in March 2015. It has become the authoritative Internet medical surgery platform in China. It has signed more than 40,000 experts from the top director level of the top three hospitals at home and abroad, and 100,000 grassroots doctors, over 1,000. Home-based cooperative hospital.

InVision

Angel Round in 2016
Shanghai Invision Health Technology Company Limited is a digital technology agency focused on the medical industry. Established in 2013 and based in Shanghai, China, the company integrates advanced digital technologies with industry-specific knowledge to enhance communication and information dissemination in healthcare. Invision specializes in developing medical mobile applications, producing 3D medical visuals, and creating digital display solutions. Its innovative use of virtual reality technology aims to streamline the communication of medical information, thereby improving engagement and understanding within the medical community.

CN-Healthcare

Series B in 2016
CN-Healthcare provides online health data and aims to integrate updates and data about the healthcare business. In order to provide customers with access to current healthcare information and increase public understanding of the health industry, the platform focuses on providing medical resource integration services. The products offered by the platform include health industry websites, mobile newspapers, and mobile medical applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.